EMAIL THIS PAGE TO A FRIEND

Clinical and experimental immunology

Interaction of lectin pathway of complement-activating pattern recognition molecules with mycobacteria.


PMID 25041480

Abstract

We have demonstrated that mannose-binding lectin (MBL) recognizes various slow-growing, pathogenic mycobacteria [Mycobacterium tuberculosis (MTB), M. bovis, M. kansasii, M. gordonae] as well as non-pathogenic M. smegmatis. Recognition resulted in activation of the lectin pathway (LP) of complement and an enhancement of phagocytosis (shown for M. tuberculosis). Although MBL may be considered the main factor activating the LP upon recognition of mycobacteria, involvement of ficolins has also to be considered. Interaction of ficolin-3 with M. tuberculosis, M. bovis and M. kansasii, and ficolin-1 with M. tuberculosis and M. bovis was shown for the first time. Binding of recombinant MBL or ficolin-3 to MTB H37 Rv led to the agglutination of bacteria and promoted their phagocytosis, but little effect was apparent with ficolin-1 or ficolin-2. Data from Western blots suggest mannosylated lipoarabinomannan (ManLAM) to be one of the main cell components of slow-growing mycobacteria, involved in LP activation. However, the LP was also activated by other cell fractions. Results presented here supplement considerably the data concerning the ability of complement-activating lectins to interact with mycobacteria. Ficolins (especially ficolin-3) might influence host response to infection and thus have clinical significance, at least as disease modifiers.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1405803
Anti-FCN1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA000685
Anti-FCN1 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2100804
Anti-FCN1 antibody produced in rabbit, affinity isolated antibody
HPA001295
Anti-FCN1 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1410379
Anti-FCN1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB1405804
Anti-FCN2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1401133
Anti-FCN2 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB2105454
Anti-FCN2, (N-terminal) antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB1401430
Anti-FCN3 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB2104813
Anti-FCN3, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB1402192
Monoclonal Anti-FCN1 antibody produced in mouse, clone 2B7, purified immunoglobulin, buffered aqueous solution
SAB1402990
Monoclonal Anti-FCN3 antibody produced in mouse, clone 4B4, ascites fluid
A8625
N-Acetyl-D-glucosamine, ≥99%
C8H15NO6
A3286
N-Acetyl-D-glucosamine, suitable for cell culture, BioReagent
C8H15NO6
A4106
N-Acetyl-D-glucosamine, ≥95% (HPLC)
C8H15NO6
PHR1432
N-Acetylglucosamine, Pharmaceutical Secondary Standard; Certified Reference Material
C8H15NO6